[JALOGO] [MEDSCAPE] In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

[bold]For Full Conference Attendance:[/bold]  [bold]For Physicians[/bold]  Medscape, LLC designates this live event for up to [italic]22.5 AMA PRA Category 1 Credit(s)™.[/italic] Physicians should claim only the credit commensurate with the extent of their participation in the activity.  [bold]For Nurses[/bold] Awarded 22.5 contact hour(s) of nursing continuing professional development for RNs and APNs; final contact hours in the area of pharmacology will be posted on the conference platform. [bold]For Pharmacists[/bold] Medscape designates this continuing education activity for Knowledge-based 16.5 contact hours and 1.650 CEUs. [bold]For Radiology Technologists [/bold] This activity will be submitted to the American Society of Radiologic Technologists (ASRT) for 6.0 hours of ARRT Category A continuing education credit. [bold]Session 1: BREAST CANCER RISK ASSESSMENT AND SCREENING For Physicians [/bold] Medscape, LLC designates this live activity for a maximum of 3.0 [italic]AMA PRA Category 1 Credit(s)™. [/italic]Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Awarded 3.0 contact hour(s) of nursing continuing professional development for RNs and APNs; [TBD] contact hours in the area of pharmacology. [bold]For Radiology Technologists [/bold] This activity will be submitted to the American Society of Radiologic Technologists (ASRT) for 3.0 hours of ARRT Category A continuing education credit. [bold]Session 2: PET IMAGING AND BEYOND For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 3.0 [italic]AMA PRA Category 1 Credit(s)™. [/italic]Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses [/bold] Awarded 3.0 contact hour(s) of nursing continuing professional development for RNs and APNs; [TBD] contact hours in the area of pharmacology. [bold]For Radiology Technologists [/bold] This activity will be submitted to the American Society of Radiologic Technologists (ASRT) for 3.0 hours of ARRT Category A continuing education credit. [bold]Session 3: EARLY DISEASE CONSIDERATIONS IN HR-POSITIVE BREAST CANCER For Physicians [/bold] Medscape, LLC designates this live activity for a maximum of 2.0 [italic]AMA PRA Category 1 Credit(s)™. [/italic]Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses [/bold] Awarded 2.0 contact hour(s) of nursing continuing professional development for RNs and APNs; [TBD] contact hours in the area of pharmacology. [bold]For Pharmacists [/bold] Medscape designates this continuing education activity for Knowledge-based 2.0 contact hours and 0.200 CEUs. See individual session Universal Activity Number: JA0007105-0000-22-174-L01-P. [bold]Session 4: METASTATIC DISEASE CONSIDERATIONS IN HR-POSITIVE BREAST CANCER For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 2.0 [italic]AMA PRA Category 1 Credit(s)™. [/italic]Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses [/bold] Awarded 2.0 contact hour(s) of nursing continuing professional development for RNs and APNs; [TBD] contact hours in the area of pharmacology. [bold]For Pharmacists [/bold] Medscape designates this continuing education activity for Knowledge-based 2.0 contact hours and 0.200 CEUs. See individual session Universal Activity Number: JA0007105-0000-22-175-L01-P. [bold]Session 5: SPECIAL TOPICS IN HR-POSITIVE BREAST CANCER For Physicians [/bold] Medscape, LLC designates this live activity for a maximum of 2.0 [italic]AMA PRA Category 1 Credit(s)™. [/italic]Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses [/bold] Awarded 2.0 contact hour(s) of nursing continuing professional development for RNs and APNs; [TBD] contact hours in the area of pharmacology. [bold]For Pharmacists [/bold] Medscape designates this continuing education activity for Knowledge-based 2.0 contact hours and 0.200 CEUs. See individual session Universal Activity Number: JA0007105-0000-22-176-L01-P. [bold]Session 6: EARLY DISEASE CONSIDERATIONS IN HER2-POSITIVE BREAST CANCER For Physicians [/bold] Medscape, LLC designates this live activity for a maximum of 2.0 [italic]AMA PRA Category 1 Credit(s)™. [/italic]Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses [/bold] Awarded 2.0 contact hour(s) of nursing continuing professional development for RNs and APNs; [TBD] contact hours in the area of pharmacology. [bold]For Pharmacists [/bold] Medscape designates this continuing education activity for Knowledge-based 2.0 contact hours and 0.200 CEUs. See individual session Universal Activity Number: JA0007105-0000-22-177-L01-P. [bold]Session 7: METASTATIC DISEASE CONSIDERATIONS IN HER2-POSITIVE BREAST CANCER For Physicians [/bold] Medscape, LLC designates this live activity for a maximum of 2.0 [italic]AMA PRA Category 1 Credit(s)™. [/italic]Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses [/bold] Awarded 2.0 contact hour(s) of nursing continuing professional development for RNs and APNs; [TBD] contact hours in the area of pharmacology. [bold]For Pharmacists[/bold] Medscape designates this continuing education activity for Knowledge-based 2.0 contact hours and 0.200 CEUs. See individual session Universal Activity Number: JA0007105-0000-22-178-L01-P. [bold]Session 8: SPECIAL TOPICS IN HER2-POSITIVE BREAST CANCER For Physicians [/bold] Medscape, LLC designates this live activity for a maximum of 2.0 [italic]AMA PRA Category 1 Credit(s)™. [/italic]Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses [/bold] Awarded 2.0 contact hour(s) of nursing continuing professional development for RNs and APNs; [TBD] contact hours in the area of pharmacology. [bold]For Pharmacists [/bold] Medscape designates this continuing education activity for Knowledge-based 2.0 contact hours and 0.200 CEUs. See individual session Universal Activity Number: JA0007105-0000-22-179-L01-P. [bold]Session 9: EARLY DISEASE CONSIDERATIONS IN TRIPLE NEGATIVE BREAST CANCER For Physicians [/bold] Medscape, LLC designates this live activity for a maximum of 2.0 [italic]AMA PRA Category 1 Credit(s)™. [/italic]Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses [/bold] Awarded 2.0 contact hour(s) of nursing continuing professional development for RNs and APNs; [TBD] contact hours in the area of pharmacology. [bold]For Pharmacists [/bold] Medscape designates this continuing education activity for Knowledge-based 2.0 contact hours and 0.200 CEUs. See individual session Universal Activity Number: JA0007105-0000-22-180-L01-P. [bold]Session 10: METASTATIC DISEASE CONSIDERATIONS IN TRIPLE NEGATIVE BREAST CANCER For Physicians [/bold] Medscape, LLC designates this live activity for a maximum of 2.5 [italic]AMA PRA Category 1 Credit(s)™. [/italic]Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses [/bold] Awarded 2.5 contact hour(s) of nursing continuing professional development for RNs and APNs; [TBD] contact hours in the area of pharmacology. [bold]For Pharmacists [/bold] Medscape designates this continuing education activity for Knowledge-based 2.5 contact hours and 0.250 CEUs. See individual session Universal Activity Number: JA0007105-0000-22-181-L01-P.